Intracellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. Learn more
Launch date
Employees
Market cap
AUD12.3b
Enterprise valuation
AUD10.7b (Public information from Sep 2024)
Share price
€67 23I.F
New York City New York (HQ)
Authorizing premium user...